A randomized study of the effect of fish oil on n-3 fatty acid incorporation and nutritional status in lung cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A randomized study of the effect of fish oil on n-3 fatty acid incorporation and nutritional status in lung cancer patients. / Andersen, Jens Rikardt; Dannerfjord, Stina Hjerrild; Nørgaard, Michael; Lauritzen, Lotte; Lange, Peter; Jensen, N Aa; Boisen, L W; Jensen, R G; Andersen, M J ; Sørensen, J B.
In: Austin Journal of Nutrition & Metabolism, Vol. 2, No. 1, 1011, 2015.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A randomized study of the effect of fish oil on n-3 fatty acid incorporation and nutritional status in lung cancer patients
AU - Andersen, Jens Rikardt
AU - Dannerfjord, Stina Hjerrild
AU - Nørgaard, Michael
AU - Lauritzen, Lotte
AU - Lange, Peter
AU - Jensen, N Aa
AU - Boisen, L W
AU - Jensen, R G
AU - Andersen, M J
AU - Sørensen, J B
N1 - CURIS 2015 NEXS 133
PY - 2015
Y1 - 2015
N2 - Long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) have been proposed to have beneficial effect on cancer cachexia. The aims of the present study were to a) determine the incorporation of n-3 LCPUFA in erythrocytes (RBC) as a measurement of compliance to fish oil (FO)-supplement in lung cancer patients undergoing anti-neoplastic therapy; and b) evaluate the effect of the FO-supplement on weight-loss, mid arm muscle circumference, energy and protein intake, hand grip strength and quality of life. Forty-two patients with advanced lung cancer were randomized immediately after referral to ingest either 20 ml of FO or 20 ml of rapeseed oil (RO) daily. Patients were evaluated every three weeks. Twenty-five patients participated in the study for more than 21 days. The RBC content in FO-group increased with 35%, 137% and 44%, respectively (p < 0.001, p < 0.001 and p < 0.001), but did not change in the ROg roup. Neither intention-to-treat analysis nor per-protocol-analysis revealed any statistically significant differences between the groups with respect to clinical outcomes.
AB - Long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) have been proposed to have beneficial effect on cancer cachexia. The aims of the present study were to a) determine the incorporation of n-3 LCPUFA in erythrocytes (RBC) as a measurement of compliance to fish oil (FO)-supplement in lung cancer patients undergoing anti-neoplastic therapy; and b) evaluate the effect of the FO-supplement on weight-loss, mid arm muscle circumference, energy and protein intake, hand grip strength and quality of life. Forty-two patients with advanced lung cancer were randomized immediately after referral to ingest either 20 ml of FO or 20 ml of rapeseed oil (RO) daily. Patients were evaluated every three weeks. Twenty-five patients participated in the study for more than 21 days. The RBC content in FO-group increased with 35%, 137% and 44%, respectively (p < 0.001, p < 0.001 and p < 0.001), but did not change in the ROg roup. Neither intention-to-treat analysis nor per-protocol-analysis revealed any statistically significant differences between the groups with respect to clinical outcomes.
M3 - Journal article
VL - 2
JO - Austin Journal of Nutrition & Metabolism
JF - Austin Journal of Nutrition & Metabolism
IS - 1
M1 - 1011
ER -
ID: 135550138